Login / Signup
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Cosimo Di Raimondo
Farah R Abdulla
Jasmine Zain
Christiane Querfeld
Steven T Rosen
Published in:
British journal of haematology (2019)
Keyphrases
</>
diffuse large b cell lymphoma
epstein barr virus
multiple myeloma
advanced non small cell lung cancer
newly diagnosed
stem cell transplantation